Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
amantadine neuronal acetylcholine receptor subunit alpha-3 small molecule NA drugbank Adverse reaction to drug[MeSHID:D064420]
Communicable Diseases[MeSHID:D003141]
Parkinsonian Disorders[MeSHID:D020734]
Muscle strain[MeSHID:D013180]
Infection[MeSHID:D007239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved antagonist
amantadine neuronal acetylcholine receptor subunit alpha-4 small molecule NA drugbank Adverse reaction to drug[MeSHID:D064420]
Communicable Diseases[MeSHID:D003141]
Parkinsonian Disorders[MeSHID:D020734]
Muscle strain[MeSHID:D013180]
Infection[MeSHID:D007239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved antagonist
amantadine neuronal acetylcholine receptor subunit alpha-7 small molecule NA drugbank Adverse reaction to drug[MeSHID:D064420]
Communicable Diseases[MeSHID:D003141]
Parkinsonian Disorders[MeSHID:D020734]
Muscle strain[MeSHID:D013180]
Infection[MeSHID:D007239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved antagonist
amantadine dopamine d2 receptor small molecule NA drugbank Adverse reaction to drug[MeSHID:D064420]
Communicable Diseases[MeSHID:D003141]
Parkinsonian Disorders[MeSHID:D020734]
Muscle strain[MeSHID:D013180]
Infection[MeSHID:D007239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved agonist
amantadine glutamate receptor ionotropic, nmda 3a small molecule NA drugbank Adverse reaction to drug[MeSHID:D064420]
Communicable Diseases[MeSHID:D003141]
Parkinsonian Disorders[MeSHID:D020734]
Muscle strain[MeSHID:D013180]
Infection[MeSHID:D007239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved antagonist
click here to return to the previous page